Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB

S. Baig, S. Qayyum, N. Saifullah, N. Ahmed (Karachi, Pakistan)

Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Session: Tuberculosis: from epidemiology to therapy 2
Session type: Thematic Poster Session
Number: 2672
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Baig, S. Qayyum, N. Saifullah, N. Ahmed (Karachi, Pakistan). Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB. Eur Respir J 2014; 44: Suppl. 58, 2672

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016

Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013



Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Genotype MTBDR (Hain) test in suspected MDR-TB patients
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012



Efficacy of treatment of MDR/XDR TB patients based on rapid diagnostics of M. tuberculosis drug resistance by GenoType MTBDRplus and GenoType MTBDRsl (Hain Lifescience GmbH, Germany)
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Early tuberculosis treatment monitoring by Xpert® MTB/RIF
Source: Eur Respir J 2012; 39: 1269-1271
Year: 2012


MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012